Silvia S Pierangeli
Overview
Explore the profile of Silvia S Pierangeli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1451
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang G, Pierangeli S, Willis R, Gonzalez E, Petri M, Khan M
PLoS One
. 2016 Oct;
11(10):e0164739.
PMID: 27749917
Even though systemic lupus erythematosus (SLE) is associated with high morbidity and mortality rates among young and middle-aged women, the molecular mechanisms of disease pathogenesis are not fully understood. Previous...
2.
Tebo A, Willis R, Jaskowski T, Guerra M, Pierangeli S, Salmon J, et al.
Clin Chim Acta
. 2016 Jun;
460:107-13.
PMID: 27346478
Background: The objective of this investigation was to examine the clinical significance of IgA anti-β2 glycoprotein I (anti-β2GPI) antibodies and the inter-assay relationships between kits for their determination. Methods: Serum...
3.
Willis R, Pierangeli S, Jaskowski T, Malmberg E, Guerra M, Salmon J, et al.
Am J Clin Pathol
. 2016 Jun;
145(6):796-805.
PMID: 27267373
Objectives: To investigate the performance characteristics and impact of newly developed reference calibrators on the commutability between anti-β2 glycoprotein I (anti-β2 GPI) immunoassays in antiphospholipid syndrome (APS) and/or systemic lupus...
4.
Willis R, Pierangeli S
Auto Immun Highlights
. 2015 May;
2(2):35-52.
PMID: 26000118
Antiphospholipid antibodies (aPL) are associated with the recurrent pregnancy loss and thrombosis that characterizes the antiphospholipid antibody syndrome (APS). Although the ontogeny of these pathogenic antibodies has not been fully...
5.
Ripoll V, Lambrianides A, Pierangeli S, Poulton K, Ioannou Y, Heywood W, et al.
Blood
. 2014 Oct;
124(25):3808-16.
PMID: 25301710
The effects of immunoglobulin G (IgG) from patients with the antiphospholipid syndrome (APS) upon monocyte activation have not been fully characterized. We carried out a comprehensive proteomic analysis of human...
6.
Pericleous C, Ruiz-Limon P, Romay-Penabad Z, Marin A, Garza-Garcia A, Murfitt L, et al.
Rheumatology (Oxford)
. 2014 Oct;
54(4):722-7.
PMID: 25273993
Objective: IgG aPL against domain I of β2-glycoprotein I (β2GPI) [anti-DI (aDI)] is associated with the pathogenesis of APS, an autoimmune disease defined by thrombosis and pregnancy morbidity. To date,...
7.
Zandman-Goddard G, Pierangeli S, Gertel S, Blank M
J Autoimmun
. 2014 Jun;
54:72-80.
PMID: 24972993
Tolerogenic dendritic cells (tDCs) have the potential to control the outcome of autoimmunity by modulating the immune response. The aim of this study was to uncover the tolerance efficacy attributed...
8.
Meroni P, Biggioggero M, Pierangeli S, Sheldon J, Zegers I, Borghi M
Nat Rev Rheumatol
. 2013 Nov;
10(1):35-43.
PMID: 24275965
Autoantibody measurement is an excellent tool to confirm the diagnosis of rheumatic autoimmune diseases. Hence, reliability and harmonization of autoantibody testing are essential, but these issues are still a matter...
9.
Murthy V, Willis R, Romay-Penabad Z, Ruiz-Limon P, Martinez-Martinez L, Jatwani S, et al.
Arthritis Rheum
. 2013 Aug;
65(12):3186-93.
PMID: 23983008
Objective: To examine the prevalence of isolated IgA anti-β2 -glycoprotein I (anti-β2 GPI) positivity and the association of these antibodies, and a subgroup that bind specifically to domain IV/V of...
10.
Erkan D, Willis R, Murthy V, Basra G, Vega J, Ruiz-Limon P, et al.
Ann Rheum Dis
. 2013 Aug;
73(6):1176-80.
PMID: 23933625
Objective: To determine if proinflammatory and prothrombotic biomarkers are differentially upregulated in persistently antiphospholipid antibody (aPL)-positive patients, and to examine the effects of fluvastatin on these biomarkers. Methods: Four groups...